LundaTec AB – Trademark Portfolio

Entity Type: 09

LundaTec AB holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include LUNDAMED, LUNDATEC, LUNDACARE, and LUNDAPHARMA. The owner is based in Lund.

Lund 22370 , SE

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

LundaTec AB's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does LundaTec AB have?

LundaTec AB has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.

What trademark classes does LundaTec AB file in?

LundaTec AB files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are LundaTec AB's most well-known trademarks?

LundaTec AB's registered trademark portfolio includes well-known marks such as LUNDAMED, LUNDATEC, LUNDACARE, and LUNDAPHARMA. These are among 6 currently registered trademarks in the portfolio.

What is LundaTec AB's trademark registration success rate?

LundaTec AB has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.